CDMO

At the end of a major investment program, Indena has now completed its CDMO offering. Currently in full operation is the high containment facility, which can handle HPAPIs of synthetic, natural or fermented origin with an OEL as low as 20 ng/m³, a further extension of Indena’s well established HPAPI manufacturing capacity.
Other state-of-the-art technologies now on stream include organic solvent spray dryers, a GMP pilot pharmaceutical plant and a multipurpose fermentation department for toxic compounds. So if you’re looking for the ideal partner for contract development and manufacturing, Indena is the natural place to go.